In human skeletal muscle cells, chemerin release was associated with insulin resistance at the level of lipogenesis and insulin-induced antilipolysis in adipocytes owing to activation of p38 MAPK, NF-κB, and extracellular signal-regulated kinase (ERK)-1/2 by chemerin (63). This evidence concerns the gene MAPK3 and Insulin resistance.